Camlin Fine Sciences Limited
Camlin Fine Sciences is engaged in the Business of Speciality Chemicals.
What Camlin files
- Others88
- Investor Meet28
- Important23
- Updates14
- Board Meeting11
- PPTs8
Camlin Fine Sciences shut its Diphenol Plant (5.06% turnover) due to raw material scarcity, ensuring no impact on downstream products. A subsequent fire caused 2 Cr loss, fully insured. Vanillin production temporarily halted, set to restart swiftly.
Camlin Fine temporarily shut its Diphenol plant (5.06% of FY25 turnover, ~INR 43.52 Cr) due to raw material issues; downstream production unaffected. A fire at the plant caused an insured INR 2 Cr loss. Ethyl Vanillin output resumes in 48 hours, no sales impact expected.
Camlin Fine Sciences' wholly-owned subsidiary, CFS Europe S.p.A., is undergoing judicial liquidation in Italy. This unit contributed ₹78.74 Cr (4.72%) to turnover and ₹85.12 Cr (9.73%) to net worth last year. Proceeds, if any, will be received post-liquidation.
Camlin Fine Sciences' Brazilian subsidiary faced a fire at one of its blend plants, stopping operations there. Damage assessment is ongoing, but the company has adequate insurance coverage. Its other blend plant continues to operate, limiting overall business impact.
Company announces its 32nd Annual General Meeting (AGM) will be held via video conferencing. The FY24-25 Annual Report is available on their website. Physical shareholders must update KYC details, including PAN, bank, and contact information, to ensure smooth electronic receipt of future payments like dividends. This streamlines investor interactions.